Wed Mar 27,
By Emma Hitt, PhD
ATLANTA (Reuters Health) - Two preliminary studies may have identified a new target for the diagnosis and treatment of cancers of the gastrointestinal tract, such as colon and esophageal cancer.
Coincidentally, this target is the same molecule activated by a bacterial toxin that causes diarrhea, suggesting a way to prevent diarrhea, researchers say. In fact, they note, the toxin that causes diarrhea could eventually be put to use as a cancer therapy.